|
TMEM87A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.390210E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.178800E-01 |
| Normal-vs-Stage2 |
4.051800E-01 |
| Normal-vs-Stage3 |
7.805200E-01 |
| Normal-vs-Stage4 |
2.637200E-01 |
| Stage1-vs-Stage2 |
9.468800E-01 |
| Stage1-vs-Stage3 |
5.897600E-01 |
| Stage1-vs-Stage4 |
3.800600E-01 |
| Stage2-vs-Stage3 |
6.225200E-01 |
| Stage2-vs-Stage4 |
4.131400E-01 |
| Stage3-vs-Stage4 |
3.266000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.483200E-01 |
| Normal-vs-AfricanAmerican |
1.191800E-01 |
| Normal-vs-Asian |
6.029400E-01 |
| Caucasian-vs-AfricanAmerican |
5.067000E-01 |
| Caucasian-vs-Asian |
9.951800E-01 |
| AfricanAmerican-vs-Asian |
8.079400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.239400E-01 |
| Normal-vs-Female |
1.286050E-02 |
| Male-vs-Female |
3.047500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.240400E-01 |
| Normal-vs-Extreme_Weight |
3.877400E-01 |
| Normal-vs-Obese |
4.106800E-01 |
| Normal-vs-Extreme_Obese |
9.778400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.955600E-01 |
| Normal_Weight-vs-Obese |
7.862200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.952600E-01 |
| Extreme_Weight-vs-Obese |
9.047400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.183600E-01 |
| Obese-vs-Extreme_Obese |
6.828200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.972000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.274400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.454200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.806600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.852200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.025000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.083400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.413700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.708600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.723200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.461800E-02 |
| Normal-VS-Type2 PRCC |
7.241200E-01 |
| Normal-VS-KIRP CIMP |
2.128200E-01 |
| Normal-VS-Unclassified PRCC |
6.374600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.385500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.258400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.007000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.274300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.323200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.142600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.867400E-01 |
| Normal-vs-N1 |
6.853000E-01 |
| Normal-vs-N2 |
2.592400E-01 |
| N0-vs-N1 |
2.762000E-01 |
| N0-vs-N2 |
1.357980E-01 |
| N1-vs-N2 |
5.963200E-01 |
|
|
